×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Insomnia Market

ID: MRFR/Pharma/0151-HCR
80 Pages
Rahul Gotadki
February 2026

EMEA Insomnia Market Research Report Information By Types Of Therapy (Pharmacological Therapy and Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablets and Others), By Type Of Diseases Condition (Poor Quality Of Sleep, Sleep Maintenance and Other) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Insomnia Market Infographic
Purchase Options

Europe Insomnia Market Summary

The Europe EMEA Insomnia market is poised for substantial growth, projected to reach 2.09 USD Billion by 2035 from a base of 0.5 USD Billion in 2024.

Key Market Trends & Highlights

EMEA Insomnia Key Trends and Highlights

  • The Europe EMEA Insomnia market is valued at 0.5 USD Billion in 2024 and is expected to grow to 2.09 USD Billion by 2035.
  • The market is anticipated to experience a compound annual growth rate (CAGR) of 13.91% from 2025 to 2035.
  • Increasing awareness of sleep disorders is likely to drive market expansion, contributing to the overall growth.
  • Growing adoption of innovative sleep solutions due to rising health consciousness is a major market driver.

Market Size & Forecast

2024 Market Size 0.5 (USD Billion)
2035 Market Size 2.09 (USD Billion)
CAGR (2025-2035) 13.91%

Major Players

Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK), CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Market Segment Insights

EMEA Insomnia Type Insights

Europe, the Middle East and Africa insomnia market has been segmented on the basis of types of therapy which comprises pharmacological therapy and non-pharmacological therapy. Pharmacological therapy is further segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Non pharmacological treatment are further segmented into relaxation therapy, cognitive behavioural therapy, sleep hygiene education, stimulus control, paradoxical intention and other. 

EMEA Insomnia Drug Formulation Insights

By drug formulation they are segmented as capsules, tablet and others. 

EMEA Insomnia Disease Insights

On the basis of type of disease they are poor quality of sleep, sleep maintenance and other.

Get more detailed insights about Europe Insomnia Market

Key Companies in the Europe Insomnia Market include

Future Outlook

Europe Insomnia Market Future Outlook

Report Scope

Attribute/Metric Details
  Market Size   USD 2.09 Billion
  CAGR   13.91%
  Base Year   2022
  Forecast Period   2025-2035
  Historical Data  2021
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Target Antigen, Application and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors  Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland). Others players are  Flynn Pharma (UK) CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)
  Key Market Opportunities   Increase in the setups of research & development centers and the inclination of top companies toward the developing countries boost
  Key Market Drivers prevalence of cancers is increasing the demand for effective treatment The growth of the obese population

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

Research Approach

Research Methodology on Europe Insomnia Market

1. Introduction

The purpose of this research methodology is to provide a comprehensive overview of the methodology that will be employed to carry out the research project titled “Europe Insomnia Market - Forecast to 2030”. As this research involves studying the various aspects of the insomnia market in the Europe region, a detailed and comprehensive methodology is followed in order to ensure that the best possible results are obtained from the study.

2. Research Questions

  • What are the factors driving the growth of the Europe insomnia market?
  • What are the challenges and opportunities encountered in the Europe insomnia market?
  • What are the trends witnessed in the Europe insomnia market?
  • What is the competitive landscape in the Europe insomnia market?
  • What is the current and future potential of the Europe insomnia market?

3. Research Philosophy

The research philosophy adopted for this study is based on the interpretive approach, which allows for the investigation of the dynamic and complex relationships between different actors present in this market. The interpretive approach is particularly suitable for this study, as it allows for an in-depth and contextualized understanding of the market and its dynamics.

4. Nature of the Study

The nature of this study is descriptive, as it seeks to generate an in-depth understanding of the Europe insomnia market and its various aspects. The research involves gathering and analyzing both qualitative and quantitative data to identify the factors that are driving the market and the trends that are impacting its progress.

5. Data Collection Method

The primary data collection methods that are used for this study are survey techniques and secondary data sources. The survey techniques involve conducting interviews with various stakeholders in the European insomnia market, such as industry experts, government officials, and healthcare professionals. The survey questionnaire is designed in such a way that it captures the relevant information about the participant’s knowledge of the market and its dynamics. Secondary data sources include published reports by research organizations, journals, and other publications.

6. Sampling Method

The sampling method adopted for this study is a non-probability convenience sampling technique. This technique is used to ensure the targeted population is adequately represented in the sample. In order to ensure the reliability and validity of the sample, care is taken to ensure that the participants for the survey are selected through a systematic process and that no bias or preference is shown towards any particular participant or group.

7. Data Analysis

The data collected through the survey and the secondary sources are analyzed using qualitative and quantitative methods. Qualitative methods such as content analysis and thematic analysis are employed to identify the major drivers of the market and the trends that are impacting the progress of the market. Quantitative methods such as descriptive statistics and correlation analysis are used to identify the strengths and weaknesses of the various stakeholders in the market.

8. Conclusion

This research methodology summarizes the various methods that are employed for the research project titled “Europe Insomnia Market - Forecast to 2030”. The interpretive research philosophy has been adopted for the study, and data collection methods include both survey techniques and secondary data sources. The data collected is analyzed using both qualitative and quantitative methods, and the major limitations of the study have been identified.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions